1-6 of 6
Changhong Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Phosphorylation State of Ezh2 Determines Its Capacity to Maintain CD8 + Memory T Cells for Antitumor Immunity

Shan He, PhD, Yongnian Liu, Lijun Meng, Hongxing SUN, Ying Wang, Yun Ji, Janaki Purushe, BS, Pan Chen, Changhong Li, Jozef Madzo, Jean-Pierre Issa, MD, Jonathan Soboloff, Ran Reshef, MD, Bethany Moore, Luca Gattinoni, Yi Zhang, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4455.
https://doi.org/10.1182/blood.V130.Suppl_1.4455.4455
Published: 2017
Journal Articles

Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice

Qingrong Huang, Shan He, Yuanyuan Tian, Yuting Gu, Pan Chen, Changhong Li, Jiefang Huang, Yongnian Liu, Hongshuang Yu, Min Jin, Shaoyan Hu, Qing Tong, Anqi Ma, Jian Jin, Elizabeth Hexner, Henry Fung, Ran Reshef, Yi Zhang, Yanyun Zhang
Journal: Blood
Blood (2017) 129 (20): 2737–2748.
https://doi.org/10.1182/blood-2016-08-735886
Published: 2017
Includes: Supplemental data
Journal Articles

Pharmacological Inhibition of Hsp90 Destabilizes the Histone Methyltransferase Ezh2 in Alloreactive T Cells and Reduces Graft-Versus-Host Disease While Retaining Anti-Leukemic Effects in Mice

Qingrong Huang, Shan He, Yuanyuan Tian, Changhong Li, Yuting Gu, Pan Chen, Jiefang Huang, Yongnian Liu, Min Jin, Qi Cao, Ran Reshef, MD, Yi Zhang, Yanyun Zhang
Journal: Blood
Blood (2015) 126 (23): 234.
https://doi.org/10.1182/blood.V126.23.234.234
Published: 2015
Journal Articles

Targeting on the Stem Cell Niche Can Protect Hematopoietic Stem Cell from Chemotherapy and G-CSF

Sidan Li, MD, Qiongli Zhai, PhD, Dehui Zou, MD, Changhong Li, Lugui Qiu, MD
Journal: Blood
Blood (2014) 124 (21): 5790.
https://doi.org/10.1182/blood.V124.21.5790.5790
Published: 2014
Journal Articles

Hypermethylation of TAp73 Suppresses ABL1-Involved DNA Damage Response in Multiple Myeloma

Mu Hao, PhD, Yu Qin, PhD, Meirong Zang, PhD, Yan Xu, MD PhD, Gang An, MD PhD, Changhong Li, MD, Ye Yang, PhD, Zhimin Gu, PhD, Fenghuang Zhan, MD PhD, Lugui Qiu, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3374.
https://doi.org/10.1182/blood.V124.21.3374.3374
Published: 2014
Journal Articles

Serum Mir-4254, Mir-19a and Mir-33b Are Potential Markers For Diagnosis and Prognostic Evaluation In Multiple Myeloma

Mu Hao, PhD., Meirong Zang, Qin Yu, Li Fei, Wenjuan Yang, Xiaoyan Feng, Fang Qi, Gang An, Changhong Li, Yan Xu, MD., Fenghuang Zhan, MD&PhD, Lugui Qiu, MD
Journal: Blood
Blood (2013) 122 (21): 3222.
https://doi.org/10.1182/blood.V122.21.3222.3222
Published: 2013